{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:09:02Z","timestamp":1779289742027,"version":"3.51.4"},"reference-count":42,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T00:00:00Z","timestamp":1645315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Exper Ophthalmology"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>To study the visual outcomes of neovascular AMD (nAMD) treated with anti\u2010vascular endothelial growth factor (VEGF) drugs at national level.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Multicenter national database of nAMD eyes treated with anti\u2010VEGF intravitreal injections (ranibizumab, aflibercept, bevacizumab) in fixed bimonthly (FB) or treat\u2010and\u2010extend (TAE) regimens. Demographics, visual acuity (VA) in logarithm of the minimum angle of resolution (logMAR) ETDRS letters at baseline and subsequent visits, number of injections and visits data were collected using a validated web\u2010based tool (Fight Retinal Blindness!).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>1273 eyes (1014 patients) were included, 971 treatment na\u00efve (TN) and 302 previously treated (PT). Baseline VA (mean\u2009\u00b1\u2009SD) was 57.5 (\u00b119.5) and 62.2 (\u00b117) (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.001), and 24\u2009months final VA was 60.4 (\u00b121.2) and 58.8 (\u00b121.1) (<jats:italic>p<\/jats:italic>\u00a0=\u00a00.326), respectively. Mean VA change at 12\/24\u2009months was +4.2\/+2.9 letters in TN eyes and +0.1\/\u22123.4 letters in PT eyes (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001\/<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The percentage of \u226515 letters gainers\/losers at 24\u2009months was 24.8%\/14.5% in TN, and 10.3%\/15.7% in PT eyes. The median number of injections\/visits at 12\u2009months was 7\/9 in TN and 6\/8 in PT (<jats:italic>p<\/jats:italic>\u00a0=\u00a00.002\/<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and at 24\u2009months was 11\/16 in TN and 11\/14 in PT (<jats:italic>p<\/jats:italic>\u00a0=\u00a00.329\/<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Study drugs included ranibizumab (39.5%), aflibercept (41.2%) and bevacizumab (19.3%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Independent, large\u2010scale national audits are feasible if committed health care professionals are provided with efficient information technology systems to do them. The results described here represent an adequate measurement of the quality of care delivered nationwide and benchmark the clinical management of nAMD at a country level compared to other real\u2010world international cohorts.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ceo.14054","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T07:54:09Z","timestamp":1643788449000},"page":"312-324","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Creation of a neovascular age\u2010related macular degeneration national database using a web\u2010based platform: <scp>Fight Retinal Blindness Spain.<\/scp> Report 1: Visual outcomes"],"prefix":"10.1111","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2338-8143","authenticated-orcid":false,"given":"Javier","family":"Zarranz\u2010Ventura","sequence":"first","affiliation":[{"name":"Hospital Cl\u00ednic de Barcelona  Barcelona Spain"},{"name":"Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS)  Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0182-7950","authenticated-orcid":false,"given":"Alba","family":"Parrado\u2010Carrillo","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednic de Barcelona  Barcelona Spain"},{"name":"Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS)  Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9070-9803","authenticated-orcid":false,"given":"Vuong","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Save Sight Institute, Sydney Medical School, University of Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Sararols","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3 Privada Hospital Asil Granollers  Granollers Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5255-8426","authenticated-orcid":false,"given":"Gonzaga","family":"Garay\u2010Aramburu","sequence":"additional","affiliation":[{"name":"OSI Araba  Vitoria Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5048-4846","authenticated-orcid":false,"given":"Mart\u00edn","family":"Puzo","sequence":"additional","affiliation":[{"name":"Hospital Universitario Miguel Servet  Zaragoza Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5312-8900","authenticated-orcid":false,"given":"Carolina","family":"Arruabarrena","sequence":"additional","affiliation":[{"name":"Hospital Universitario Principe de Asturias  Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-0539","authenticated-orcid":false,"given":"Marc","family":"Figueras\u2010Roca","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednic de Barcelona  Barcelona Spain"},{"name":"Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS)  Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8580-0274","authenticated-orcid":false,"given":"Mark C.","family":"Gillies","sequence":"additional","affiliation":[{"name":"Save Sight Institute, Sydney Medical School, University of Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1812-9323","authenticated-orcid":false,"given":"Ricardo P.","family":"Casaroli\u2010Marano","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednic de Barcelona  Barcelona Spain"},{"name":"Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS)  Barcelona Spain"},{"name":"Department of Surgery, School of Medicine, Universitat de Barcelona  Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"from the writing committee of the Fight Retinal Blindness Spain (FRB! Spain) Users Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,2,20]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2017.12.002"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305702"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2019.5540"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14399"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.11.031"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.04.026"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2017.108"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.10.010"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001496"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.02.009"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2016.149"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-308077"},{"issue":"4","key":"e_1_2_8_14_1","first-page":"1","article-title":"Anti\u2010vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema","volume":"4","author":"Mehta H","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2016.90"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002670"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2012.02493.x"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/iae.0b013e31827b6324"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000548"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13539"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-018-1005-x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/346360"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1159\/000445724"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1159\/000453281"},{"issue":"9","key":"e_1_2_8_25_1","first-page":"430","article-title":"Outcomes in patients receiving fixed\u2010dosed aflibercept for treatment\u2010na\u00efve neovascular age\u2010related macular degeneration during one year of routine clinical practice","volume":"94","author":"Oca L\u00e1zaro AI","year":"2019","journal-title":"Arch la Soc Espa\u00f1ola Oftalmol (English Ed)"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-020-05016-9"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318296b271"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-008-0926-0"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-308166"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305327"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-014-3217-7"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13946"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S92627"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.08.009"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.07.014"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.01.013"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01236-x"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000003128"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2016.12.004"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2019.09.009"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2018.24.2-a.s3"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0747-x"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9821509"}],"container-title":["Clinical &amp; Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ceo.14054","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ceo.14054","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ceo.14054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T04:15:23Z","timestamp":1692504923000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ceo.14054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,20]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1111\/ceo.14054"],"URL":"https:\/\/doi.org\/10.1111\/ceo.14054","archive":["Portico"],"relation":{},"ISSN":["1442-6404","1442-9071"],"issn-type":[{"value":"1442-6404","type":"print"},{"value":"1442-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,20]]},"assertion":[{"value":"2021-11-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}